» Articles » PMID: 10843958

Bronchial Inflammation: Its Relationship to Colonizing Microbial Load and Alpha(1)-antitrypsin Deficiency

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2000 Jun 10
PMID 10843958
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophil elastase is capable of generating many of the features of chronic bronchial disease. In patients with COPD, airways inflammation with neutrophil recruitment and elastase release is positively correlated with colonizing bacterial load in the stable clinical state (p < 0.0005). In addition, alpha(1)-antitrypsin deficiency is associated with a greater neutrophil load, higher elastase activity, leukotriene-B(4) concentration, and serum protein leak than matched patients without deficiency (p < 0.005). These data confirm an effect of bronchial colonization on airways inflammation in COPD and indicate the role of alpha(1)-antitrypsin in its modulation.

Citing Articles

Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype.

Pragman A, Hodgson S, Wu T, Zank A, Reilly C, Wendt C ERJ Open Res. 2024; 10(1).

PMID: 38333651 PMC: 10851948. DOI: 10.1183/23120541.00595-2023.


The emerging role of proteases in α-antitrypsin deficiency and beyond.

Fazleen A, Wilkinson T ERJ Open Res. 2021; 7(4).

PMID: 34820446 PMC: 8607071. DOI: 10.1183/23120541.00494-2021.


The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial.

Campos M, Geraghty P, Holt G, Mendes E, Newby P, Ma S Am J Respir Crit Care Med. 2019; 200(3):318-326.

PMID: 30965011 PMC: 6680306. DOI: 10.1164/rccm.201901-0010OC.


Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.

Strange C, Senior R, Sciurba F, ONeal S, Morris A, Wisniewski S Ann Am Thorac Soc. 2015; 12(10):1551-60.

PMID: 26153726 PMC: 4627425. DOI: 10.1513/AnnalsATS.201503-143OC.


Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.

Siva R, Bafadhel M, Monteiro W, Brightling C, Pavord I Int J Chron Obstruct Pulmon Dis. 2014; 9:179-86.

PMID: 24532969 PMC: 3923615. DOI: 10.2147/COPD.S55419.